Literature DB >> 17103165

Stress-induced abnormalities in myocardial perfusion imaging that are not related to perfusion but are of diagnostic and prognostic importance.

John P Higgins1, Johanna A Higgins, Gethin Williams.   

Abstract

INTRODUCTION: Certain stress-induced ancillary findings on myocardial perfusion scintigraphy increase the likelihood that the patient has coronary artery disease (CAD); furthermore, among CAD patients, they indicate more severe and extensive disease, placing these patients at higher risk for future cardiac events. Indeed, in studies with no obvious perfusion defect yet with serious CAD--for example, balanced ischemia--it can be these high-risk findings that necessitate invasive intervention. DISCUSSION: Besides reversible perfusion defects, such findings include increased pulmonary radiotracer uptake, transient cavity dilatation, increased end-diastolic or end-systolic volume, decreased post-stress ejection fraction, and increased right ventricular tracer uptake on stress images. The pathophysiology underlying these findings is clearly different as they do not always occur together, and each independently predicts more severe and extensive CAD. In the current review, these findings are defined and their significance in diagnosing patients with suspected or known CAD is discussed.

Entities:  

Mesh:

Year:  2006        PMID: 17103165     DOI: 10.1007/s00259-006-0293-1

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  72 in total

1.  Gated single-photon emission tomography imaging protocol to evaluate myocardial stunning after exercise.

Authors:  J Hashimoto; A Kubo; R Iwasaki; S Iwanaga; H Mitamura; S Ogawa; S Kosuda
Journal:  Eur J Nucl Med       Date:  1999-12

2.  Value of peripheral vascular endothelial function in the detection of relative myocardial ischemia in asymptomatic type 2 diabetic patients who underwent myocardial perfusion imaging.

Authors:  Georgios I Papaioannou; Christos Kasapis; Richard L Seip; Neil J Grey; Deborah Katten; Frans J Th Wackers; Silvio E Inzucchi; Samuel Engel; Amy Taylor; Lawrence H Young; Deborah A Chyun; Janice A Davey; Ami E Iskandrian; Robert E Ratner; Evelyn C Robinson; Stella Carolan; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2006 May-Jun       Impact factor: 5.952

3.  The role of left ventricular hypertrophy and diabetes in the presence of transient ischemic dilation of the left ventricle on myocardial perfusion SPECT images.

Authors:  Louise Emmett; Michael Magee; S Ben Freedman; Hans Van der Wall; Vivienne Bush; Joseph Trieu; William Van Gaal; Kevin C Allman; Leonard Kritharides
Journal:  J Nucl Med       Date:  2005-10       Impact factor: 10.057

4.  The value and correlates of left ventricular cavity assessment in dipyridamole 201Tl SPET studies.

Authors:  S I Heiba; M D Cerqueira; A F Jacobson; M J Ferreira
Journal:  Nucl Med Commun       Date:  1998-05       Impact factor: 1.690

5.  Comparison of pulmonary uptake with transient cavity dilation after dipyridamole Tl-201 perfusion imaging.

Authors:  Christopher L Hansen; Puxiao Cen; Benjamin Sanchez; Reginald Robinson
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

6.  Clinical correlates of Tc-99m sestamibi lung uptake.

Authors:  J B Choy; W D Leslie
Journal:  J Nucl Cardiol       Date:  2001 Nov-Dec       Impact factor: 5.952

7.  Increased extra-cardiac background uptake on immediate and delayed post-stress images with 99Tcm sestamibi: determinants, independence, and significance of counts in lung, abdomen and myocardium.

Authors:  G A Hurwitz
Journal:  Nucl Med Commun       Date:  2000-10       Impact factor: 1.690

8.  Relationship of transient ischemic dilation in dipyridamole myocardial perfusion imaging and stress-induced changes of functional parameters evaluated by Tl-201 gated SPECT.

Authors:  Guang-Uei Hung; Kung-Wei Lee; Ching-Pei Chen; Wan-Yu Lin; Kuang-Tao Yang
Journal:  J Nucl Cardiol       Date:  2005 May-Jun       Impact factor: 5.952

9.  Quantification of pulmonary thallium-201 activity after upright exercise in normal persons: importance of peak heart rate and propranolol usage in defining normal values.

Authors:  K A Brown; C A Boucher; R D Okada; H W Strauss; G M Pohost
Journal:  Am J Cardiol       Date:  1984-06-01       Impact factor: 2.778

10.  [Transient ischemic dilatation of the left ventricle observed on dipyridamole-stressed thallium-201 scintigraphy].

Authors:  T Toyama; B E Caner; N Tamaki; K Yamamoto; T Nakashima; T Odori; N Takahashi; J Mifune; M Ohnaka; T Tanaka
Journal:  Kaku Igaku       Date:  1993-06
View more
  4 in total

1.  EANM/ESC guidelines for radionuclide imaging of cardiac function.

Authors:  B Hesse; T B Lindhardt; W Acampa; C Anagnostopoulos; J Ballinger; J J Bax; L Edenbrandt; A Flotats; G Germano; T Gmeiner Stopar; P Franken; A Kelion; A Kjaer; D Le Guludec; M Ljungberg; A F Maenhout; C Marcassa; J Marving; F McKiddie; W M Schaefer; L Stegger; R Underwood
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-04       Impact factor: 9.236

2.  Combining cardiac magnetic resonance and computed tomography coronary calcium scoring: added value for the assessment of morphological coronary disease?

Authors:  Paul Stolzmann; Hatem Alkadhi; Hans Scheffel; André Plass; Sebastian Leschka; Volkmar Falk; Sebastian Kozerke; Christophe Wyss; Olivio F Donati
Journal:  Int J Cardiovasc Imaging       Date:  2010-10-31       Impact factor: 2.357

Review 3.  Shining Damaged Hearts: Immunotherapy-Related Cardiotoxicity in the Spotlight of Nuclear Cardiology.

Authors:  David Kersting; Stephan Settelmeier; Ilektra-Antonia Mavroeidi; Ken Herrmann; Robert Seifert; Christoph Rischpler
Journal:  Int J Mol Sci       Date:  2022-03-30       Impact factor: 5.923

4.  Incremental Diagnostic Performance of Combined Parameters in the Detection of Severe Coronary Artery Disease Using Exercise Gated Myocardial Perfusion Imaging.

Authors:  Chia-Ju Liu; Yen-Wen Wu; Kuan-Yin Ko; Yi-Chieh Chen; Mei-Fang Cheng; Ruoh-Fang Yen; Kai-Yuan Tzen
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.